Healthcare & Life Sciences

Replay Holdings

About

Replay Holdings develops a platform to deliver large DNA payloads efficiently to any cell type, featuring a high-capacity HSV vector for gene delivery and a hypoimmunogenic iPSC therapeutic platform targeting the cell and gene therapy market.

Explore Replay Holdings's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.